The COVID-19 pandemic has forced an abrupt transition to Telehealth for drug addiction treatment. People in treatment, or seeking treatment, may be less able to access medication for treating drug addiction, and I am focusing this discussion on opioid use disorder (OUD) treatment. How has the COVID-19 pandemic and Telehealth affected access to MAT (methadone and buprenorphine) for OUD, to you knowledge?